share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Nov 15 06:02

Summary by Moomoo AI

Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 69,126 shares of common stock, with an aggregate market value of approximately $711,615, on 11/14/2024. The shares to be sold were acquired through restricted stock vesting on various dates including 08/01/2024, 08/17/2024, 08/18/2024, and 11/01/2024, with additional shares acquired via stock option exercise on 01/12/2024. The securities were obtained directly from Arcutis Biotherapeutics. In the past three months, Burnett has sold a total of 17,169 shares, generating gross proceeds of $147,892.
Arcutis Biotherapeutics, Inc. officer Burnett Patrick is set to sell 69,126 shares of common stock, with an aggregate market value of approximately $711,615, on 11/14/2024. The shares to be sold were acquired through restricted stock vesting on various dates including 08/01/2024, 08/17/2024, 08/18/2024, and 11/01/2024, with additional shares acquired via stock option exercise on 01/12/2024. The securities were obtained directly from Arcutis Biotherapeutics. In the past three months, Burnett has sold a total of 17,169 shares, generating gross proceeds of $147,892.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more